NRG Therapeutics

Stevenage, United Kingdom · Founded 2018 · Privately Held (backing)

Developer of a drug discovery platform intended to develop therapeutic approaches to restore mitochondrial function. NRG Therapeutics is based in Stevenage, United Kingdom and was founded in 2018. Its last reported valuation was $51.9 million in Sep 2025. It has raised $95 million.

Last reported valuation

$51.9M

Oct 2026

Priced at

—

Total raised

$95.0M

Last round

—

How much has NRG Therapeutics raised?

$95.0Macross 0 recorded rounds

Free account

More of NRG Therapeutics with a free account

·The complete investor list: 17 names
·Watch NRG Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

NRG Therapeutics investors

17 investors are on record for NRG Therapeutics, including Innovate UK, British Business Bank, M Ventures and SV Health Investors.

For fundraisers

Raising for a company like NRG Therapeutics?

17 investors have backed NRG Therapeutics.

See all 17 investors →

Frequently asked about NRG Therapeutics

How much has NRG Therapeutics raised?: NRG Therapeutics has raised $95.0M in total across 0 recorded funding rounds.